Mindray Medical International Limited

$MR - NYSE - Healthcare Equipment/Supplies
0 LAST
0 CHANGE $
0 CHANGE %
loader
ON 0
WATCHLISTS

COMMUNIQUÉ DETAILS

Up 0 0 Down
Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission

SHENZHEN, China, April 29, 2014 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that it has filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included audited financial statements for the year ended December 31, 2013. An electronic version of Mindray's Annual Report on Form 20-F is available on Mindray's investor relations website at http://ir.mindray.com or http://www.sec.gov.

Investors may obtain a printed copy of Mindray's audited financial statements free of charge by contacting Mindray Investor Relations either by:

Email: ir@mindray.com
Phone: +86-755-8188-8023
Address: Investor Relations
Mindray Building
Keji 11th Road South, High-tech Industrial Park
Nanshan, Shenzhen 518057
P.R.China

About Mindray

We are a leading developer, manufacturer, and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey, and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://ir.mindray.com.

For investor and media inquiries, please contact:

In the U.S:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com

In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com

SOURCE Mindray Medical International Limited

SHARE THIS: Twitter StockTwits LinkedIn Google Plus SHORT URL: http://bdvt.co/dLVB

SIGN IN TO BOARDVOTE

FORGOT PASSWORD?